Study on efficacy and safety of Hochuekkito for the treatment of partial paralysis as a complication of cerebrovascular disorder
Phase 2
- Conditions
- Patients undergoing rehabilitation for partial paralysis as a complication of cerebrovascular disorder
- Registration Number
- JPRN-UMIN000021801
- Lead Sponsor
- Department of Rehabilitation Tsuruoka Kyoritu Rehabilitation Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have any of the following conditions: 1)Insufficient nutrition intake (less than 1,400kcal/day) 2)CRP of 10g/dL or more 3)Grade 2 or severer on the physical disability certificate or Grade 3 or severer certification of long-term care need since before the onset of cerebrovascular disorder 4)Use of any Kampo medicine within 4 weeks before study initiation 5)Serious comorbidities (e.g., hepatic, renal, cardiac, hematological, and metabolic diseases) 6)Any other condition assessed as inappropriate for study participation by the investigator or subinvestigator (hereinafter referred to as "investigators, etc.")
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FIM(Functional Independence Measure)
- Secondary Outcome Measures
Name Time Method Alb,Body weight,BMI,%Ideal body weight,Lymphocyte number,Hb,CRP,Incidence rate of complication